Spago Nanomedical AB (publ) announced today that the independent Data Monitoring Committee (DMC) recommends that the ongoing clinical phase I/IIa study Tumorad-01 with the drug candidate 177Lu-SN201 ...
LUND, SE / ACCESSNewswire / March 10, 2026 / Spago Nanomedical AB (publ)(STO.SPAGO.ST)(FRA.7UX.F) announced today that Torsten Malmström has assumed the position of DirectorCMC & Supply... SPAGO) ... Spago Nanomedical.
LUND, SE / ACCESSNewswire / February 5, 2026 / Spago Nanomedical (STO.SPAGO.ST)(FRA.7UX.F) ... As we sum up 2025, it is clear that the year has been both eventful and pivotal for Spago Nanomedical ... Mats Hansen, CEO Spago Nanomedical AB ... Spago Nanomedical.
After the final award had been handed out, stars dispersed across Los Angeles for exclusive after-parties at hot spots like Spago and the Chateau Marmont... .